Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV

NCT00011011 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

94

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: ALVAC(2)120(B,MN)GNP (vCP1452)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)